Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction

Top Cited Papers
Open Access
Abstract
Previous studies have shown improvement in left ventricular function after intracoronary injection of autologous cells derived from bone marrow (BMC) in the acute phase of myocardial infarction. We designed a randomized, controlled trial to further investigate the effects of this treatment.